Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06445036 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism

Study acronym: THYPARS
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 21, 2025 (before its estimated July 27, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv4
  2. Start date: Sep 1, 2024 to Feb 27, 2025
    • Primary and study completion dates: Feb 1, 2025 to Jul 27, 2025
    • Site details revised
    v3
  3. Study title revisedv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.
Trial Details
NCT Number NCT06445036
Lead Sponsor Dacima Consulting
Collaborators: Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques
Conditions
(from sponsor)		 Hypoparathyroidism, Pseudo Hypoparathyroidism
Related terms Hypoparathyroidism, Pseudohypoparathyroidism
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov